Compass Point reiterates Coinbase stock Sell rating on derivatives expansion

Compass Point reiterated a Sell rating on Coinbase and kept its $140 price target, implying substantial downside versus the $180.86 share price. The firm argued that expanded U.S. crypto derivatives may deliver limited revenue upside for Coinbase because perpetual-style products are already cannibalizing spot trading fees, while competition from Kraken, Robinhood, Interactive Brokers and others is intensifying. The article also notes mixed analyst reactions to Coinbase’s latest earnings, with multiple price-target changes but a generally cautious near-term revenue outlook.

Analysis

This is less a structural win for COIN than a margin-compression event disguised as industry expansion. The common mistake is to model derivatives as incremental TAM without accounting for the fact that the first dollars of activity will mostly re-route high-intent users away from higher-take spot and brokerage flows, while pricing power remains weak because product differentiation is minimal and transfer friction is near zero.

Second-order winners are the venues that can monetize infrastructure rather than flow: CME should capture a disproportionate share of institutional hedging demand because listed futures benefit from balance-sheet trust, existing distribution, and overnight risk management habits. IBKR and other multi-asset brokers can also gain share by bundling access into a broader trading relationship, which makes the economics stickier than a pure-play crypto venue. The real threat to COIN is that it is being forced to compete on execution and product breadth while carrying a premium valuation tied to a high-throughput retail commission model that is becoming less durable.

The catalyst window matters: over the next 1-3 quarters, the market will likely reward headline product expansion before the P&L shows the cannibalization. That sets up a potential trap where implied growth stays high while actual take-rate and transaction revenue disappoint, especially if crypto volatility remains muted and user activity migrates to perpetual-style products with lower friction. A reversal would require either a sustained crypto beta upswing that lifts all boats, or evidence that COIN can monetize derivatives users via wallet, prime, or subscription revenue rather than trading fees alone.

Consensus appears too willing to extrapolate share gains from being early in U.S. crypto derivatives. The more interesting read is that regulatory normalization lowers barriers for everyone else, which compresses the option value of COIN's ecosystem moat faster than the market is pricing in. In that setup, the downside is not just multiple compression; it's the market re-rating COIN from platform premium to ex-growth transaction processor.

Key Decisions for Investors

• Short COIN into any post-announcement strength; tactical horizon 1-3 months. Risk/reward favors downside toward the prior sell-side target zone if transaction activity stays soft and derivatives cannibalize spot.
• Pair trade: long CME / short COIN for 3-6 months. CME has better institutional trust, stronger distribution, and more durable monetization per unit of volume; COIN carries the higher take-rate risk.
• Add IBKR on weakness as a relative winner in multi-asset access. Time horizon 6-12 months; benefit comes from embedded trading relationships and lower churn versus single-product crypto venues.
• Buy COIN downside via put spreads 2-4 months out rather than outright short if borrow or squeeze risk is a concern. Structure for a modest move lower while capping premium bleed if crypto beta spikes.
• Fade any rally in crypto-exposed brokers until evidence emerges that derivatives volumes are additive, not cannibalistic. If COIN cannot show fee retention within 1-2 quarters, reduce any long exposure materially.